George Decou v. Takeda Pharmaceuticals America, Inc.

SETTLED

Trial
08/27/15 – 10/06/15

Summary

A Nevada state court judge overseeing a potentially $2 billion jury trial over the alleged bladder cancer risks of Takeda Pharmaceutical Co Ltd.’s blockbuster diabetes drug Actos announced Wednesday that the pharmaceutical company and two plaintiffs had tentatively resolved their claims, likely ending a trial that began in August and was expected to continue for weeks.

Click here for more in-depth coverage via the CVN News Blog.

Outcome

Settled

Sessions

AM Session
Openings
3 Chapters
PM Session
Openings
2 Chapters
AUG
27
AM Session
Openings
3 Chapters
AUG
28
AM Session
Plaintiff Witness(es)
2 Chapters
SEP
3
AM Session
Plaintiff Witness(es)
2 Chapters
SEP
25

Recording Disclaimer: This proceeding was recorded in full.

AudioCaseFiles

Exclusive audio opinions to enhance your law school experience

AudioCaseFiles

Essentials

The most important and informative moments of each trial

Essentials

Training Libraries

Trial Advocacy, Rules of Evidence and Appellate Advocacy

Training

  • Follow Us